Literature DB >> 30903457

Alternative Splicing Rescues Loss of Common Gamma Chain Function and Results in IL-21R-like Deficiency.

David Illig1, Marta Navratil2,3, Jadranka Kelečić4, Raffaele Conca1, Iva Hojsak3,5,6, Oleg Jadrešin5, Marijana Ćorić7, Jurica Vuković8, Meino Rohlfs1, Sebastian Hollizeck1, Jens Bohne9, Christoph Klein1, Daniel Kotlarz10.   

Abstract

Inborn errors in interleukin 2 receptor, gamma (IL2RG) perturb signaling of the common gamma chain family cytokines and cause severe combined immunodeficiency (SCID). Here, we report two brothers suffering from chronic cryptosporidiosis, severe diarrhea, and cholangitis. Pan T, B, and NK cell numbers were normal, but immunophenotyping revealed defective B cell differentiation. Using whole exome sequencing, we identified a base pair deletion in the first exon of IL2RG predicted to cause a frameshift and premature stop. However, flow cytometry revealed normal surface expression of the IL-2Rγ chain. While IL-2, IL-7, and IL-15 signaling showed only mild defects of STAT5 phosphorylation in response to the respective cytokines, IL-4- and IL-21-induced phosphorylation of STAT3 and STAT6 was markedly reduced. Examination of RNA isoforms detected alternative splicing downstream of IL2RG exon 1 in both patients resulting in resolution of the predicted frameshift and 16 mutated amino acids. In silico modeling suggested that the IL-2Rγ mutation reduces the stabilization of IL-4 and IL-21 cytokine binding by affecting the N-terminal domain of the IL-2Rγ. Thus, our study shows that IL2RG deficiency can be associated with differential signaling defects. Confounding effects of alternative splicing may partially rescue genetic defects and should be considered in patients with inborn errors of immunity.

Entities:  

Keywords:  IL-21R; IL-2R; SCID; immunodeficiency; splicing

Year:  2019        PMID: 30903457     DOI: 10.1007/s10875-019-00606-7

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

Review 1.  Severe combined immunodeficiencies (SCID).

Authors:  A Fischer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.

Authors:  V Stephan; V Wahn; F Le Deist; U Dirksen; B Broker; I Müller-Fleckenstein; G Horneff; H Schroten; A Fischer; G de Saint Basile
Journal:  N Engl J Med       Date:  1996-11-21       Impact factor: 91.245

Review 3.  Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency.

Authors:  Kerstin Felgentreff; Ruy Perez-Becker; Carsten Speckmann; Klaus Schwarz; Krzysztof Kalwak; Gasper Markelj; Tadej Avcin; Waseem Qasim; E G Davies; Tim Niehues; Stephan Ehl
Journal:  Clin Immunol       Date:  2011-05-30       Impact factor: 3.969

4.  Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants.

Authors:  R H Buckley; R I Schiff; S E Schiff; M L Markert; L W Williams; T O Harville; J L Roberts; J M Puck
Journal:  J Pediatr       Date:  1997-03       Impact factor: 4.406

5.  Structural and biophysical studies of the human IL-7/IL-7Ralpha complex.

Authors:  Craig A McElroy; Julie A Dohm; Scott T R Walsh
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

6.  Functional role of interleukin-4 (IL-4) and IL-7 in the development of X-linked severe combined immunodeficiency.

Authors:  S Kumaki; N Ishii; M Minegishi; S Tsuchiya; D Cosman; K Sugamura; T Konno
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

7.  Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients.

Authors:  J L Stephan; V Vlekova; F Le Deist; S Blanche; J Donadieu; G De Saint-Basile; A Durandy; C Griscelli; A Fischer
Journal:  J Pediatr       Date:  1993-10       Impact factor: 4.406

Review 8.  New insights into the regulation of T cells by gamma(c) family cytokines.

Authors:  Yrina Rochman; Rosanne Spolski; Warren J Leonard
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

Review 9.  Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution.

Authors:  Rebecca H Buckley
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

10.  Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system.

Authors:  Sherry L LaPorte; Z Sean Juo; Jana Vaclavikova; Leremy A Colf; Xiulan Qi; Nicola M Heller; Achsah D Keegan; K Christopher Garcia
Journal:  Cell       Date:  2008-01-25       Impact factor: 41.582

View more
  3 in total

1.  The effect of mutatio-type on proteo-phenotype and clinico-phenotype in selected primary immunodeficiencies.

Authors:  Sevil Oskay Halacli
Journal:  Immunol Res       Date:  2021-10-07       Impact factor: 2.829

2.  Novel Hemizygous IL2RG p.(Pro58Ser) Mutation Impairs IL-2 Receptor Complex Expression on Lymphocytes Causing X-Linked Combined Immunodeficiency.

Authors:  Elina A Tuovinen; Juha Grönholm; Tiina Öhman; Sakari Pöysti; Raine Toivonen; Anna Kreutzman; Kaarina Heiskanen; Luca Trotta; Sanna Toiviainen-Salo; John M Routes; James Verbsky; Satu Mustjoki; Janna Saarela; Juha Kere; Markku Varjosalo; Arno Hänninen; Mikko R J Seppänen
Journal:  J Clin Immunol       Date:  2020-02-19       Impact factor: 8.317

3.  Case Report: Interleukin-2 Receptor Common Gamma Chain Defect Presented as a Hyper-IgE Syndrome.

Authors:  Brahim Belaid; Lydia Lamara Mahammed; Aida Mohand Oussaid; Melanie Migaud; Yasmine Khadri; Jean Laurent Casanova; Anne Puel; Nafissa Ben Halla; Reda Djidjik
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.